Finance

Lists
NRXP:NASDAQ
NRX Pharmaceuticals Inc
US$ २.८५
०.००%
(०.००) 1D
US$ २.८५
०.००% (०.००)
Pre-market
Closed: अक्टोबर १२, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRXP...
Mkt. cap
१२.३४ करोड
Avg. vol.
६.१४ लाख
Volume
८.१७ हजार
52-wk high
US$ ५.०६
52-wk low
US$ १.६२
EPS
-US$ ०.७४
Beta
२.०८
Shares outstanding
४.३३ करोड
No. of employees
२९
Mkt. cap
१२.३४ करोड
Avg. vol.
६.१४ लाख
Volume
८.१७ हजार
52-wk high
US$ ५.०६
52-wk low
US$ १.६२
EPS
-US$ ०.७४
Beta
२.०८
Shares outstanding
४.३३ करोड
No. of employees
२९
News stories
From web sources and news partners
About NRX Pharmaceuticals Inc
CEO-
Employees२९
Founded२०१५
HeadquartersWilmington, डेलावेयर, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to NRXP in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NRXP in the last 3 months.
Highest
Current US$ २.८५
US$ ५०.०० (+१,६५४.३९%)
Average
US$ ३५.०० (+१,१२८.०७%)
Lowest
US$ १०.०० (+२५०.८८%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
US$ ५०.००
+१,६५४.४%
09/30/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
US$ ४५.००
+१,४७८.९%
09/21/2026
Thomas Shrader
BTIG
Buy
Maintained
US$ १०.००
+२५०.९%
09/14/2026
Elemer Piros
Lucid Capital
Buy
Initiated
US$ ४९.००
+१,६१९.३%
05/13/2026
Jason Kolbert
D. Boral Capital
Buy
Maintained
US$ ३४.००
+१,०९३%
04/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२.४२ लाख
९.८३ लाख
१०.६८ लाख
११.०१ लाख
Cost of goods sold
९७.०० हजार
४.०८ लाख
६.३१ लाख
६.७५ लाख
Cost of revenue
९७.०० हजार
४.०८ लाख
६.३१ लाख
६.७५ लाख
Research and development expenses
१४.२९ लाख
५.५८ लाख
१३.०९ लाख
२१.१६ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२८.०८ लाख
४५.६९ लाख
३८.१३ लाख
४७.४५ लाख
Operating expense
४२.६३ लाख
५१.६९ लाख
५१.८५ लाख
६९.२७ लाख
Total operating expenses
४३.६० लाख
५५.७७ लाख
५८.१६ लाख
७६.०२ लाख
Operating income
-४१.१८ लाख
-४५.९४ लाख
-४७.४८ लाख
-६५.०१ लाख
Other non operating income
-३.६६ लाख
१५.९३ लाख
३५.३८ लाख
-९७.८४ लाख
EBT including unusual items
-५८.९० लाख
३.६० लाख
-१४.३० लाख
-१.६५ करोड
EBT excluding unusual items
-४४.८२ लाख
-३६.६८ लाख
-१४.३६ लाख
-१.६५ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-५८.९० लाख
३.६० लाख
-१४.३० लाख
-१.६५ करोड
Net profit margin
-२,४३३.८८%
३६.६२%
-१३३.९०%
-१,५००.४५%
Earnings per share
-०.५१
०.१८
-०.०४
-०.२४
Interest and investment income
२.०० हजार
४.०० हजार
५.०० हजार
६.०० हजार
Interest expense
-
-६.७१ लाख
-२.३३ लाख
-२.४० लाख
Net interest expenses
२.०० हजार
-६.६७ लाख
-२.२८ लाख
-२.३४ लाख
Depreciation and amortization charges
२६.०० हजार
४२.०० हजार
६३.०० हजार
६६.०० हजार
EBITDA
-४१.०९ लाख
-४५.५२ लाख
-४६.८५ लाख
-६४.३० लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू